Cargando…
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
Epstein-Barr virus (EBV) persists in nasopharyngeal (NPC) and gastric carcinomas (EBVaGC) in a tightly latent form. Cytolytic virus activation (CLVA) therapy employs gemcitabine and valproic acid (GCb+VPA) to reactivate latent EBV into the lytic phase and antiviral valganciclovir to enhance cell dea...
Autores principales: | Ramayanti, Octavia, Brinkkemper, Mitch, Verkuijlen, Sandra A. W. M., Ritmaleni, Leni, Go, Mei Lin, Middeldorp, Jaap M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923344/ https://www.ncbi.nlm.nih.gov/pubmed/29565326 http://dx.doi.org/10.3390/cancers10040089 |
Ejemplares similares
-
Vesicle‐bound EBV‐BART13‐3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV‐infections
por: Ramayanti, Octavia, et al.
Publicado: (2018) -
Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication
por: De Leo, A, et al.
Publicado: (2015) -
Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
por: Choi, Su Jin, et al.
Publicado: (2019) -
EBV-IgA antibody responses in endemic and nonendemic populations with nasopharyngeal carcinoma: tumour marker prognostication study and a cross-sectional study
por: Budiningsih, Insani, et al.
Publicado: (2023) -
Conquering the Nuclear Envelope Barriers by EBV Lytic Replication
por: Lee, Chung-Pei, et al.
Publicado: (2021)